Source: Frontiers in Neurology

Frontiers in Neurology publishes a peer-reviewed study exploring the clinical integration of artificial intelligence in the field of neurology, with a focus on diagnostic accuracy and early intervention in neurodegenerative diseases. The article assesses AI’s capacity to identify early biomarkers and assist neurologists in complex decision-making.

Ethical and legal concerns are also raised, particularly regarding algorithmic transparency, responsibility in medical errors, and the implications for patient consent. The study highlights the global push toward creating regulatory frameworks that ensure safety while enhancing diagnostic precision.

Authors advocate for collaboration between legal, medical, and tech professionals to guide AI adoption responsibly in sensitive clinical contexts.